BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35651747)

  • 21. 9-PAN promotes tubulin- and ROS-mediated cell death in human triple-negative breast cancer cells.
    Verma P; Nagireddy PKR; Prassanawar SS; Nirmala JG; Gupta A; Kantevari S; Lopus M
    J Pharm Pharmacol; 2020 Nov; 72(11):1585-1594. PubMed ID: 32959391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer.
    Kaushal T; Khan S; Fatima K; Luqman S; Khan F; Negi AS
    Curr Top Med Chem; 2022; 22(10):855-867. PubMed ID: 35331094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Panitumumab-DOTA-
    Facca VJ; Cai Z; Gopal NEK; Reilly RM
    Mol Pharm; 2022 Oct; 19(10):3652-3663. PubMed ID: 35926098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proximal discrepancy in intrinsic atomic interaction arrests G2/M phase by inhibiting Cyclin B1/CDK1 to infer molecular and cellular biocompatibility of D-limonene.
    Mandal D; Patel P; Verma SK; Sahu BR; Parija T
    Sci Rep; 2022 Oct; 12(1):18184. PubMed ID: 36307489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ziyuglycoside I Inhibits the Proliferation of MDA-MB-231 Breast Carcinoma Cells through Inducing p53-Mediated G2/M Cell Cycle Arrest and Intrinsic/Extrinsic Apoptosis.
    Zhu X; Wang K; Zhang K; Zhang T; Yin Y; Xu F
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27879682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-(Naphthalene-1-yl)-6-pyrrolidinyl-4-quinazolinone inhibits skin cancer M21 cell proliferation through aberrant expression of microtubules and the cell cycle.
    Wu YC; Hour MJ; Leung WC; Wu CY; Liu WZ; Chang YH; Lee HZ
    J Pharmacol Exp Ther; 2011 Sep; 338(3):942-51. PubMed ID: 21652781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.
    Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferative Effects of Cynara cardunculus L. var. altilis (DC) Lipophilic Extracts.
    Ramos PA; Guerra ÂR; Guerreiro O; Santos SA; Oliveira H; Freire CS; Silvestre AJ; Duarte MF
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
    Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
    Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology.
    Wu T; Xiang M; Li Y; Gao Y; Teng D; Sun M; Guo W; Zhou Y
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):341. PubMed ID: 38179762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLFN12 Over-expression Sensitizes Triple Negative Breast Cancer Cells to Chemotherapy Drugs and Radiotherapy.
    Raafat Elsayed AA; Al-Marsoummi S; Vomhof-Dekrey EE; Basson MD
    Cancer Genomics Proteomics; 2022; 19(3):328-338. PubMed ID: 35430566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation.
    Mao J; Luo QQ; Zhang HR; Zheng XH; Shen C; Qi HZ; Hu ML; Zhang H
    Chem Biol Interact; 2022 Jan; 352():109784. PubMed ID: 34932952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest.
    Wang Y; Wu N; Zhang J; Wang H; Men X
    Onco Targets Ther; 2020; 13():4089-4097. PubMed ID: 32494162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells.
    Gangapuram M; Jean R; Mazzio E; Badisa R; Eyunni S; Goodman CB; Redda KK; Soliman KF
    Anticancer Res; 2016 Oct; 36(10):5043-5052. PubMed ID: 27798863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
    Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
    Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of Diallyl Disulfide on the Proliferation and Apoptosis of Epithelial Ovarian Cancer Cells by Inducing G2/M Arrest].
    Zhang RT; Shi HR; Ren F; Liu ZY; Ji PC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Feb; 41(1):43-52. PubMed ID: 30837041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angelicin inhibits the growth and migration of triple-negative breast cancer cells.
    I-Hsiao C; Chien-Yu C; Yu-Hsuan L; I-Fen C
    Pak J Pharm Sci; 2023 Jan; 36(1):51-57. PubMed ID: 36967496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A-432411, a novel indolinone compound that disrupts spindle pole formation and inhibits human cancer cell growth.
    Chen Z; Merta PJ; Lin NH; Tahir SK; Kovar P; Sham HL; Zhang H
    Mol Cancer Ther; 2005 Apr; 4(4):562-8. PubMed ID: 15827329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chk1, but not Chk2, is responsible for G2/M phase arrest induced by diallyl disulfide in human gastric cancer BGC823 cells.
    Bo S; Hui H; Li W; Hui L; Hong X; Lin D; Dai WX; Wu YH; Ai XH; Hao J; Qi S
    Food Chem Toxicol; 2014 Jun; 68():61-70. PubMed ID: 24650757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.